This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

The pipeline is tailored to work with the PBMC 3K dataset, which is a widely used dataset provided by 10X Genomics. This dataset contains transcriptomic information derived from 3,000 individual ...

To demonstrate the effectiveness of these methods with more recent protocols, we selected thisdata set, hereafter referred to as the PBMC data. This data set is a representative of 10X Genomics's more ...

An aliquot of 20 μL of each PBMC sample was set aside for cell counting and verification ... Single cell sequencing libraries were prepared using the Chromium Controller (10x Genomics) by following ...

On thawing, the PBMC were counted using a Countess II Automated Cell Counter (Thermo Fisher), and 8700 cells for each sample were loaded individually onto the Chromium Controller (10x Genomics).

Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

Leerink Partners cut shares of 10x Genomics (NASDAQ:TXG – Free Report) from an outperform rating to a market perform rating ...

Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into a scheduled two-week trial, according to a Thursday filing in Delaware ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...

10x Genomics Price Performance Shares of TXG opened at $12.31 on Tuesday. The firm has a market cap of $1.49 billion, a PE ratio of -8.05 and a beta of 1.85. The stock’s fifty day moving average ...